Abstract |
Inflammatory bowel diseases (IBDs) are complex multifactorial immunological disorders characterized by dysregulated immune reactivity in the intestine. Here, we investigated the contribution of Qa-1-restricted CD8(+) Treg cells in regulating experimental IBD in mice. We found that CD8(+) T cells induced by T-cell vaccination ameliorated the pathological manifestations of dextran sulfate sodium induced IBD when adoptively transferred into IBD mice. In addition, CD8(+) cell suppressive activity was induced by vaccination with glatiramer acetate (GA), an FDA-approved drug for multiple sclerosis (MS). We next showed that GA-induced CD8(+) Treg cells worked in a Qa-1-dependent manner and their suppressive activity depends on perforin-mediated cytotoxicity. Finally, we confirmed the role of CD4(+) T cells in dextran sulfate sodium induced colitis progression, and clarified that GA-induced CD8(+) T cells exerted their therapeutic effects on colitis by targeting pathogenic CD4(+) T cells. Our results reveal a new regulatory role of Qa-1-restricted CD8(+) Treg cells in IBD and suggest their induction by GA vaccination as a potential therapeutic approach to IBD.
|
Authors | Yunliang Yao, Wenzheng Han, Jingjing Liang, Jian Ji, Jianli Wang, Harvey Cantor, Linrong Lu |
Journal | European journal of immunology
(Eur J Immunol)
Vol. 43
Issue 1
Pg. 125-36
(Jan 2013)
ISSN: 1521-4141 [Electronic] Germany |
PMID | 23002042
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Chemical References |
- Histocompatibility Antigens Class I
- Peptides
- Q surface antigens
- Perforin
- Glatiramer Acetate
- Dextran Sulfate
|
Topics |
- Animals
- CD4-Positive T-Lymphocytes
(immunology)
- CD8-Positive T-Lymphocytes
(immunology)
- Cells, Cultured
- Colitis
(chemically induced, drug therapy, immunology)
- Cytotoxicity, Immunologic
- Dextran Sulfate
(administration & dosage)
- Disease Models, Animal
- Glatiramer Acetate
- Histocompatibility Antigens Class I
(metabolism)
- Humans
- Immunosuppression Therapy
- Inflammatory Bowel Diseases
(therapy)
- Mice
- Mice, Inbred C57BL
- Peptides
(administration & dosage, immunology)
- Perforin
(metabolism)
- Protein Binding
- Vaccination
|